Type 1 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have Type 1 diabetes and whose blood sugar levels vary significantly and unpredictably, measured by specific medical tests showing high variability (confirm with trial site for exact measurements)
- People whose blood sugar variability has continued for more than 12 months, even while receiving the best available diabetes care from a specialist team
- People who have been supported by a specialist team experienced in insulin pumps and glucose sensors, received training in managing their insulin and blood sugar, and used pump and sensor technology together
- People whose blood sugar variability is considered severe because it causes serious, unpredictable health events that affect daily life — such as at least 2 severe low blood sugar episodes in the past 12 months that required help from another person, or at least 1 severe low blood sugar episode in the past 12 months that was life-threatening (such as coma, seizures, or serious injury), or episodes of dangerous acid build-up in the blood (ketoacidosis)
Who may not be able to join:
- People with Type 1 diabetes who do not meet the medical criteria for islet transplantation (a procedure involving transplanting insulin-producing cells)
- People who are already using a closed-loop insulin delivery system (a device that automatically adjusts insulin based on glucose readings)
- People who have previously had a kidney transplant
- People who fall under specific French legal protections for vulnerable individuals (confirm with trial site)
- People who do not wish to participate in research
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sandrine LABLANCHE, MD, PhD, University Hospital, Grenoble
Phone: +33476765509
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Describe Closed Loop (CL) failures at 12 months in patients referred to an expert center for management of unstable diabetes.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.